Interventional therapies for hepatocellular carcinoma

Cancer Imaging. 2012 Apr 5;12(1):79-88. doi: 10.1102/1470-7330.2012.0011.

Abstract

Hepatocellular carcinoma is the third most common cause of cancer-related death. In the past few years, staging systems have been developed that enable patients to be stratified into treatment algorithms in a multidisciplinary setting. Several of these treatments involve minimally invasive image-guided therapy that can be performed by radiologists.

Publication types

  • Review

MeSH terms

  • Algorithms
  • Carcinoma, Hepatocellular / drug therapy
  • Carcinoma, Hepatocellular / pathology
  • Carcinoma, Hepatocellular / radiotherapy
  • Carcinoma, Hepatocellular / surgery
  • Carcinoma, Hepatocellular / therapy*
  • Catheter Ablation*
  • Chemoembolization, Therapeutic / methods*
  • Contraindications
  • Drug Implants
  • Ethanol / administration & dosage
  • Ethanol / therapeutic use
  • Ethiodized Oil / administration & dosage
  • Ethiodized Oil / therapeutic use
  • Hepatectomy / methods
  • Hepatic Artery
  • Humans
  • Injections, Intra-Arterial
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / pathology
  • Liver Neoplasms / radiotherapy
  • Liver Neoplasms / surgery
  • Liver Neoplasms / therapy*
  • Liver Transplantation
  • Magnetic Resonance Imaging, Interventional
  • Microspheres
  • Minimally Invasive Surgical Procedures
  • Neoplasm Staging
  • Radiography, Interventional
  • Randomized Controlled Trials as Topic
  • Retrospective Studies
  • Sclerotherapy
  • Yttrium Radioisotopes / administration & dosage
  • Yttrium Radioisotopes / therapeutic use

Substances

  • Drug Implants
  • Yttrium Radioisotopes
  • Ethanol
  • Ethiodized Oil